Search Results - "Caspers, I. A."

Effect of preoperative chemotherapy on the histopathological classification of gastric cancer by Caspers, I. A., Biesma, H. D., Wiklund, K., Pontén, F., Lind, P., Nordsmark, M., Sikorska, K., Meershoek-KleinKranenbarg, E., Hartgrink, H. H., van de Velde, C. J. H., van Sandick, J. W., Verheij, M., Cats, A., van Grieken, N. C. T.

“…Background In the era of individualized gastric cancer (GC) treatment, accurate determination of histological subtype becomes increasingly relevant. As yet, it…”
Get full text

Risk factors of metachronous peritoneal carcinomatosis after potentially curative gastric cancer resection in the CRITICS trial by Caspers, Irene A, Sikorska, Karolina, Slagter, Astrid E., Meershoek – Klein Kranenbarg, Elma, Van De Velde, Cornelis J.H., Lind, Pehr A., Nordsmark, Marianne, Jansen, Edwin PM, Verheij, Marcel, van Sandick, Johanna W., Cats, Annemieke, van Grieken, Nicole C.T.

“…Abstract only 4053 Background: Peritoneal carcinomatosis (PC) is accountable for over 50% of metastatic spread in gastric cancer (GC). Little is known about…”
Get full text

The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial by Caspers, Irene A., Slagter, Astrid E., Lind, Pehr, Sikorska, Karolina, Wiklund, Katja, Pontén, Fredrik, Nordsmark, Marianne, Velde, Cornelis J. H., Kranenbarg, Elma Meershoek‐Klein, Sandick, Johanna W., Jansen, Edwin P. M., Laarhoven, Hanneke W. M., Verheij, Marcel, Grieken, Nicole C. T., Cats, Annemieke

“…Background and Objective This study aims to investigate the impact of sex on outcome measures stratified by histological subtype in patients with resectable…”
Get full text

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial by Slagter, Astrid E., Vollebergh, Marieke A., Caspers, Irene A., van Sandick, Johanna W., Sikorska, Karolina, Lind, Pehr, Nordsmark, Marianne, Putter, Hein, Braak, Jeffrey P. B. M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Jansen, Edwin P. M., Cats, Annemieke, van Laarhoven, Hanneke W. M., van Grieken, Nicole C. T., Verheij, Marcel

“…Aim To evaluate the prognostic value of tumor markers in a European cohort of patients with resectable gastric cancer. Methods We performed a post hoc analysis…”
Get full text

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial by Caspers, Irene A., Sikorska, Karolina, Slagter, Astrid E., van Amelsfoort, Romy M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Lind, Pehr, Nordsmark, Marianne, Jansen, Edwin P. M., Verheij, Marcel, van Sandick, Johanna W., Cats, Annemieke, van Grieken, Nicole C. T.

“…Gastric cancer (GC) patients at high risk of developing peritoneal metastasis (PM) as a single site of metastasis after curative treatment may be candidates…”
Get full text

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer by Slagter, Astrid E, Caspers, Irene A, van Grieken, Nicole C T, Walraven, Iris, Lind, Pehr, Meershoek-Klein Kranenbarg, Elma, Grootscholten, Cecile, Nordsmark, Marianne, van Sandick, Johanna W, Sikorska, Karolina, van de Velde, Cornelis J H, Jansen, Edwin P M, Verheij, Marcel, van Laarhoven, Hanneke W M, Cats, Annemieke

“…(1) Background: Perioperative chemotherapy is the current standard treatment for patients with resectable gastric cancer. Based on studies in patients with…”
Get full text